SU2C CATALYST RESEARCH GRANT PROGRAM WITH SUPPORT FROM ZENTALIS PHARMACEUTICALS

ENTERTAINMENT INDUSTRY FOUNDATION

Objeto

Topic: Cancer.

Destination: Support projects that investigate the use of Wee1 inhibitors to treat different types of cancer.

Budget: $800,000.

Duration: 3 years.

Are you interested in this call?

Estás interesado?

Llena el siguiente formulario para recibir más información: